Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network

Publication | Closed Access

DOI

390

Citations

References

2016

Year

Olivier Hermine, Eva Hoster, Jan Walewski, André Bosly, Stephan Stilgenbauer, Catherine Thiéblemont, Michał Szymczyk, Réda Bouabdallah, Michael Kneba, Michael Hallek,

The Lancet

Hematological MalignancyLymphoid NeoplasiaOncologyTransplantationMantle Cell LymphomaHematologyImmunologyHigh-dose CytarabineMcl YoungerImmunotherapyMedicineCell TransplantationCancer Research